CClinicalTrials.gg
Status unknownNCT03233451Updated Apr 9, 2019

Psycho-behavioral Intervention for Depression in Chronic Heart Failure

An interventional study of Psycho-behavioral intervention in Depression, sponsored by Peking University. Status unknown at 6 sites in China. Open to participants aged 60 Years to 85 Years. Per ClinicalTrials.gov, last updated 2019-04-09.

Sponsored by Peking University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
236
Allocation
Randomized
Ages
60 Years to 85 Years
Sex
All
01

Study summary

The study aims to explore the effectiveness of psycho-behavioral intervention on depressive symptoms among older adults with chronic heart failure. Meanwhile, the effect on cardiac function and quality of life will also be explored.

Read the detailed description

Depression has been one of the emerging health concerns for older adults, especially for those with chronic heart failure (CHF). It was about 4-5 times more prevalent among patients with CHF than healthy population and independently associated with poor outcome of CHF. As suggested in the clinical management guideline of CHF, it is imperative to create integrative intervention for older adults with CHF, including timely detection and intervention, and ultimately improving the clinical outcome of CHF. However, the approach appropriate for depression intervention among Chinese older adults has yet been developed. This study aims to explore the effectiveness of psycho-behavioral intervention on depression associated with chronic heart failure in old age.

02

Conditions studied

03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's planned enrollment of 236 is above the median of 72 across 3,736 interventional studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

Peking University is the lead sponsor of 411 studies on the registry; 122 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. between 60 -85 years old.
  2. male or female.
  3. Diagnosis with depression as measured with PHQ-9 score of 5 and greater;
  4. The subject is diagnosed with chronic heart failure according to their history, symptoms, signs, and adjuvant examinations (eg,echocardiography), in line with the diagnostic criteria for chronic heart failure presented in the China Heart Failure Diagnosis and Treatment Guidelines, with NYHA (New York Heart Association) grade II-III.
  5. Reading and writing competency for completing the rating scales.
  6. Sufficient physical condition, hearing and vision to ensure the completion of psychological behavior intervention.

Exclusion criteria

Exclusion Criteria:

  1. Currently taking antidepressant drugs, and drug dose is unstable.
  2. With is a serious risk of suicide, suicide attempts and suicidal behavior (HAMD17 score of 30 or above, or suicide subscale score of 3 and above,or suicide subscale score of MINI of 6 or above).
  3. Intact cognitive function with CSI-D score of less than 7.
  4. Having other major mental disorders, including Alzheimer's disease, schizophrenia, schizoaffective psychiatric disorders, delusional disorders, undefined psychotic disorders, substance and alcohol abuse
  5. Planned heart surgery within 9 months.
  6. Unable to comply with psychological intervention due to serious physical conditions -
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
236 participants (estimated)

Study arms

  • Experimental
    Interventional group

    Subjects receive guided psycho-behavioral intervention once a week for 8 weeks. After 8 weeks, the subjects will receive monthly psychological counseling for 7 months.

    Behavioral: Psycho-behavioral intervention

  • No intervention
    control group

    Subjects will receive usual care and be contacted as same frequent as the intervention group.

Interventions

  • BehavioralPsycho-behavioral intervention

    The psycho-behavioral intervention included 12-week weekly guided psychological intervention (8 modules of behavioral intervention) and 24-week monthly maintenance psychological support.

06

What researchers measure

Primary outcomes

  1. 16 Item Quick Inventory of Depressive Symptomatology Self-Report Version

    The primary outcome measure is the response rate of depression from baseline to week 12. The response rate was defined as a 50% or greater score reduction on 16 Item Quick Inventory of Depressive Symptomatology-Self-Report. The total score ranges from 0 to 27, with higher scores indicating more severe symptoms.

    Time frame: between baseline and week 12

Secondary outcomes

  1. 16 Item Quick Inventory of Depressive Symptomatology Self-Report Version

    The severity of depressive symptoms was measured with the 16 Item Quick Inventory of Depressive Symptomatology Self-Report Version. The score ranges from 0 to 27, with higher scores indicating more severe symptoms.

    Time frame: between baseline and week 1, 2, 4, 8, 24 and 36

  2. 17-Item Hamilton Rating Scale for Depression

    The severity of depressive symptoms was measured with 17-Item Hamilton Rating Scale for Depression. The 17-item Hamilton Depression Rating Scale produces a total score ranging from 0 (not at all depressed) to 52 (severely depressed).

    Time frame: between baseline and week 4, 8, 12, 24 and 36

  3. Beck Depression Inventory II

    The Beck Depression Inventory II assesses the severity of depression and produces a total score ranging from 0 to 63, with higher scores indicating more severe symptoms.

    Time frame: between baseline and week 1, 2, 4, 8, 12, 24 and 36

  4. Geriatric Depression Inventory-Self-Report

    The Geriatric Depression Inventory-Self-Report assesses the severity of depression and produces a total score ranging from 0 to 12, with higher scores indicating more severe symptoms.

    Time frame: between baseline and week 4, 8, 12, 24 and 36

  5. amino-terminal fragment of pro-B-type natriuretic peptide (NT-ProBNP)

    change of NT-ProBNP level

    Time frame: between baseline and week 12, and between baseline and week 36

  6. cardiac function

    change of ejection fraction as measured with ultrasound cardiogram

    Time frame: between baseline and week 12, and between baseline and week 36

  7. Minnesota living with heart failure questionnaire

    The health-related quality of life was measured by Minnesota Living with Heart Failure Questionnaire.The total score ranges from 0 to 105, with higher scores from best to worst health-related quality of life.

    Time frame: between baseline and week 4, 8, 12, 24 and 36

07

Study locations

6 of 6 sites recruiting
  • Beijing Anzhen Hospital, Capital Medical University
    Beijing, China
    • Jianhua He, MD · Contact
    • Jianhua He, MD · Principal investigator
    • Jin Yi, MD · Sub investigator
    • Yulan Liang · Sub investigator
    • Na Zhang, MD · Sub investigator
    Recruiting
  • Beijing Chaoyang Hospital, Capital Medical University
    Beijing, China
    • Yongdong Hu · Contact
    • Yongdong Hu · Principal investigator
    Recruiting
  • Beijing Chaoyang Third Hospital
    Beijing, China
    • Wanxin Ma · Contact
    Recruiting
  • Beijing Fengtai Tieying Hospital
    Beijing, China
    • Peiyun Sun · Contact
    • Peiyun Sun · Principal investigator
    • Ning Li · Sub investigator
    Recruiting
  • Beijing Tiancun Community Health Center
    Beijing, China
    • Qingling Yang · Contact
    • Qingling Yang · Principal investigator
    • Jing Sun · Sub investigator
    • Chong Zhang · Sub investigator
    Recruiting
  • Peking University Third Hospital
    Beijing, China
    • Yun Zhu · Contact
    • Yun Zhu · Principal investigator
    Recruiting
08

References and documents

Publications

  • Zhang Y, Lv X, Jiang W, Zhu Y, Xu W, Hu Y, Ma W, Sun P, Yang Q, Liang Y, Ren F, Yu X, Wang H. Effectiveness of a telephone-delivered psycho-behavioural intervention on depression in elderly with chronic heart failure: rationale and design of a randomized controlled trial. BMC Psychiatry. 2019 May 27;19(1):161. doi: 10.1186/s12888-019-2135-2. PubMed 31132996 ↗

Study documents

  • Statistical analysis plan · Jan 1, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — After the results of primary outcome are published, the individual participant data will only be shared anonymously based on request by email to study PI. The team using data should work with the study PI's team on data analysis and publications. The host project should be acknowledged in any submitted working paper, conference presentations and publications.

Supporting information: Study protocol, Csr, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03233451
Lead sponsor
Peking University
Responsible party
Huali Wang (Principal Investigator, Peking University) — Principal investigator
First posted
Jul 28, 2017
Start date
Aug 1, 2017
Primary completion
Dec 30, 2019 (estimated)
Completion
Dec 31, 2020 (estimated)
Last update
Apr 9, 2019

Study contacts

Huali Wang, PhD
Contact
huali_wang@bjmu.edu.cn
+86 010-82801983
Ying Zhang
Contact
zhangying0603@bjmu.edu.cn
Huali Wang, PhD
principal investigator · Peking University Institute of Mental Health

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion